Samsung has previewed what it calls a new AI-powered health companion for the Galaxy Watch, describing the feature as a health-first, always-on gateway for personalized guidance built directly into the device users already wear on their wrist. The announcement, first teased this past summer and expected to roll out more broadly in the coming months, positions Samsung alongside a crowded field of consumer tech companies racing to turn passive fitness tracking into active, AI-driven health coaching.
From Passive Tracking to Active Coaching
For most of the past decade, wearable devices like the Galaxy Watch, Apple Watch, and Fitbit have primarily functioned as passive data collectors, logging heart rate, sleep stages, and step counts for users to review after the fact. Samsung’s new AI companion aims to shift that model toward proactive engagement, using the accumulated sensor data to generate real-time suggestions, flag unusual patterns, and offer conversational guidance, a design philosophy increasingly common across the wearable industry as companies look for ways to differentiate hardware that has otherwise become fairly commoditized.
Samsung Is Racing a Crowded Field
Samsung is far from alone in this push. Meta has reportedly been developing its own AI-powered smartwatch with an integrated Meta AI assistant and health tracking features, while ring maker Oura, which has filed for an IPO seeking up to a $15.6 billion valuation, launched a dedicated women’s health AI model earlier in 2026. Smaller entrants are pushing into similar territory as well: CUDIS recently launched a ring featuring an AI-agent coach that tracks sleep, heart rate variability, and recovery, while QuantumOp has developed a Raman-spectroscopy-based ring aimed at non-invasive glucose and cortisol monitoring, reflecting how quickly the wearable health category has diversified beyond basic activity tracking.
Why the Timing Makes Sense
The push toward AI health companions arrives as digital health funding has concentrated heavily around AI-powered products, with Rock Health reporting that US digital health startups raised roughly $7.4 billion across 244 deals in the first half of 2026 alone, up from $6.4 billion in the same period a year earlier. Large, well-capitalized device makers like Samsung have an advantage that startups often lack: an installed base of millions of existing Galaxy Watch owners whose historical sensor data can be used to train and personalize AI models without the cold-start problem newer entrants face.
The Privacy and Accuracy Questions
Health technology researchers have raised two recurring concerns about this category of product. First is accuracy: consumer wearables are not medical devices in the regulatory sense, and the AI-generated health suggestions they produce are not subject to the same clinical validation the FDA requires for diagnostic tools, meaning users could receive confident-sounding guidance that has not been rigorously tested. Second is privacy, since always-on health AI companions require continuous collection of highly sensitive biometric data, raising questions about how that data is stored, whether it could be used for purposes like insurance underwriting, and what happens to it if a company is acquired or changes its data policies.
What Samsung Says It’s Trying to Solve
Samsung has framed the health companion as addressing a specific gap: most people only think about their health reactively, after a problem has already emerged, rather than proactively using the data their devices are already collecting. By surfacing patterns, such as a gradual decline in sleep quality or an unusual resting heart rate trend, before they become noticeable to the user, Samsung is betting that AI can shift consumer health behavior from reactive to preventive, a goal shared across the broader digital health and wellness industry even as the clinical evidence for such interventions remains limited.
What’s Next
Samsung has not yet confirmed a specific public launch date for the full rollout of the AI health companion feature, though the company’s pattern of previewing features months ahead of shipping suggests a release tied to an upcoming Galaxy Watch hardware cycle. The broader question for Samsung and its wearable rivals alike is whether consumers will trust AI-generated health guidance enough to act on it, and whether regulators will eventually draw a clearer line between consumer wellness features and the kind of medical claims that would require FDA oversight, a distinction that remains contested as these devices grow more sophisticated.
Photo: https://kaboompics.com/ / PEXELS via Pexels
